Mark Zuckerberg takes business calls on a jet ski wearing his $800 Meta glasses—and insists ‘the other person could not tell’

Zuckerberg renews his push for Meta smart glasses, citing Ray-Ban Display glasses pricing up to $799 and claiming sales have “tripled” year over year. However, Reality Labs posted a $19.2B loss in 2025 and Meta expects 2026 capex of up to $145B, keeping the outlook capital-intensive. Overall, the product momentum is positive, but funding burn and scalability risk likely temper sentiment for the near-term.

Analysis

This is less a near-term earnings driver than a control-point story: if glasses become the default interface for AI, Meta can deepen engagement and reduce dependence on the phone screen as the primary distribution layer. The market, however, should separate strategic optionality from near-term P&L; the first-order financial effect is still heavy cash burn and a higher bar for capex efficiency, which can cap multiple expansion if investors start treating this like an open-ended infrastructure spend.

The clearest second-order winner is the eyewear partner/distribution stack, where ESLOY has asymmetric upside from incremental units, brand halo, and lens/frame attach without bearing the same R&D burden. Losers are adjacent wearable categories that do not own an ecosystem—standalone audio/camera wearables, and eventually any smartphone-dependent accessory that can be displaced by a wrist/face-native AI interface. But if adoption stays novelty-level, the hardware economics remain irrelevant and the market is overvaluing a narrative that may not show up in operating income for years.

Catalyst timing matters: the next 1-3 months are about channel checks, holiday sell-through, and whether Meta can show retention and usage intensity rather than just shipments. Over 6-18 months, the key falsifier is simple: if capex keeps inflating while gross profit contribution from wearables remains immaterial, the stock could face margin-multiple compression even if the AI story stays intact. Consensus may be missing that the strategic thesis is real, but the monetization path is likely longer and lumpier than the market is pricing.

Key Decisions for Investors

• META: do not add on the wearable narrative alone; if the stock rallies 5-8% into the next earnings print, consider a 1-3 month put spread hedge because capex/margin risk is the cleaner near-term variable than device revenue.
• ESLOY / META pair: long ESLOY against short META over 3-6 months if channel checks confirm continued smart-glasses sell-through, because ESLOY captures hardware attach with far less balance-sheet and capex exposure.
• Watch item, not a trade yet: require evidence of active usage and retention before underwriting any upside re-rate in META; the thesis is falsified if wearables fail to show meaningful revenue contribution by the next 2 quarters.
• If META volatility compresses after earnings, favor selling upside via call spreads rather than outright longs; the current setup looks like strategic optionality with poor near-term cash conversion.